100% Audit Defense, No Extra Cost

Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach

Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach
on August 31, 2022
Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach

Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach

Healthtech firm’s development of predictive technology for oncologists assisted by government R&D tax credits because of its partnership with Boast

About: Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach

About Smirta

Cancer treatment is complicated. When patients and doctors need simplicity and efficiency to advance healing, the industry offers the opposite, complexity, and inefficiency.

Treatments involve many moving parts—scheduling, oncologists and specialists, treatment options and management, drug education, and more. Providing quality care, managing costs, and creating a simplified experience are difficult tasks for oncologist groups to deliver. Smirta is innovating technology to offer a new approach to cancer treatment resource management. The company was founded in 2018 with the goal of bringing advanced technology to healthcare—an industry that lags other industries in its use of technology. The Smirta founders felt there was an opportunity to create something new and better.

About: Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach

“Cancer patients deserve a better experience, and we know that healthcare professionals and oncologists want to give it to them,” said Bhaskar Anepu, Co-founder, Smirta. “The trick has been finding ways to remove complexity, time, and hassle from their treatment delivery process, while at the same time making healthcare professionals smarter about how they can treat their patients.”

About: Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach

Smirta has pioneered new advancements—several are patent pending—that use artificial intelligence and data integrations to provide better care and resource management to even the most experienced professional.

The company employs advanced statistical techniques to forecast patient volume and service types based on historical data. Then, sophisticated optimization algorithms evenly balance future appointments to maximize resource utilization and minimize patient wait times. The Smirta reporting interface allows users to display Chair Utilization, Optimized Schedule Template indicating staffing needs and availability, and advanced options to manually fine-tune patient schedules to accommodate varying patient needs and staffing availability

These innovative solutions are the result of passionate co-founders and dedicated employees. “Our team at Smirta is a combination of successful entrepreneurs, inventors, academic researchers, physicians, and highly skilled Software engineers with a cumulative experience of over 100 years in these fields,” said Anepu. “With these diverse backgrounds and a unified ambition, we are working to create the best products possible. Our vision is to solve mission-critical issues in health care resulting in a better experience for customers and patients.”

About: Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach

“Cancer patients deserve a better experience, and we know that healthcare professionals and oncologists want to give it to them.”

Bhaskar Anepu, CO-Founder Smirta

Smirta partnered with Boast to capitalize on the government R&D tax credit program where businesses that invest in innovation can claim a portion of that investment back. “We wanted to pursue an R&D tax credit refund with Boast once we understood the opportunity it posed for us,” said Anepu. “We love Boast’s technology-first approach which is different from traditional approaches with how it streamlines the process.”

Getting their R&D investment back is material for Smirta— it adds to their other sources of revenue to invest more in technology and innovation which helps them speed up their development cycle, get to market more quickly, and grow organically.

“The Smirta team is using their government R&D tax credits the right way,” said Alok Tyagi, CEO, Boast. “They are focused on investing in innovation and solutions that will significantly improve cancer treatments for thousands of people. It is our pleasure to support their goals and vision.”

About: Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach
About: Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach

Ready for data

Your data—and lots of it—is the key to a more accurate claim. Good thing the Boast platform is hungry for data. We securely integrate with hundreds of other systems to make capturing and qualifying your R&D investments easy, and real-time.

Smirta Innovates Faster with R&D Tax Credits and Boast

80 hours saved using Boast technology, integrations, and experts
Easier for Smirta teams, allowing them to focus instead on their innovations
Larger Refund—approximately 30% larger claim with Boast
About: Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach
Accelerate innovation with SR&ED and R&D tax incentive automation from Boast. AI.
About: Smirta Offers a Simplified Approach to Cancer Treatment Using Its Innovative Technology and Approach
Learn more about Smirta cancer treatment resource management at

Customer Success Stories

Humi
July 6, 2021 Humi Accelerates Innovation Through SR&ED Tax Credits and Its Partnership with Boast

The fast-growth Canadian HR software company invests heavily in innovation and is rewarded with high…

Boast

Boast Logo